We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Journal of Dermatological Treatment

Now an Open Access Journal

Submit Your Research

Journal of Dermatological Treatment is converting to Open Access

As of the  13th of September 2022, Journal of Dermatological Treatment will convert to an Open Access publishing model. From this date all manuscripts submitted to the journal will, if accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution.

Journal of Dermatological Treatment is an international journal which publishes research on the treatment of skin disease. The journal covers topical, systemic, phototherapeutic, and other treatment approaches with the aim of providing dermatologists practical value through cutting edge research. Authors who submit to the journal benefit from rapid peer review and dissemination.

The conversion to Open Access will ensure that research published in Journal of Dermatological Treatment is available to the widest range of clinicians and researchers possible with no barriers to access.

We look forward to receiving your submissions as the journal enters this new and exciting phase!

    Journal of Dermatological Treatment is particularly interested in receiving manuscripts on:

    • Topical and systemic dermatological therapies, including novel biologicals

    • Dermatological phototherapy

    • Dermatological surgery and lasers

    • Skin pharmacology

            There is a comprehensive description of the journal scope as well as a clear set of instructions for authors in the  journal website.  

            Interested authors should visit the Taylor & Francis Open Access Members and  Open Access Agreements pages in case they are based at an institution that may have funds available to authors wishing to publish in  Journal of Dermatological Treatment. Interested readers may also want to consider signing up to receive  latest article alerts to keep up-to-date with the latest research published in the journal. 

            Meet the Editors

            Professor Peter Van de Kerkhof started his training in Dermatology and his research on psoriasis in 1979 at the department of dermatology of the Radboud University Medical Centre. He was registered as a dermatologist in 1983. From 1991 until 2018 he was the chairman of that department. Under his guidance there was an active program on psoriasis and non-melanoma skin cancer.

            Peter van de Kerkhof worked on understanding the pathogenesis of psoriasis by studies on the transition between symptomless and clinically involved skin. He has been a principle investigator in many clinical trials. He worked on international collaborative groups on understanding the treatment selection in daily practice.

            He has published over 800 papers in peer reviewed journals and gives presentations abroad on invitation.

            Currently he is a senior Professor of the Radboud University. He is Chief medical officer of the international psoriasis council , provides consultancies for pharmaceutical companies and gives lectures and masterclasses abroad.

            Dr. Steven R. Feldman is Professor of Dermatology, Pathology, Social Sciences & Health Policy, and Molecular Medicine & Translational Science at the Wake Forest School of Medicine. He received MD and PhD degrees from Duke University and completed dermatology residency at the University of North Carolina at Chapel Hill and dermatopathology training at the Medical University of South Carolina.

            He leads the Center for Dermatology Research, a health services research center whose mission is to improve the care of patients with skin disease. He serves on the Medical Board of the National Psoriasis Foundation and directed psoriasis education programs for the American Academy of Dermatology.

            According to Expertscape.com, Feldman has been rated among the top experts in the world on psoriasis, acne and dermatology. He has given more than 700 invited lectures to dermatology groups and organizations around the world including the Pan Arab Dermatology Meeting held in Riyadh, Saudi Arabia, the Iranian Dermatology Society meeting in Tehran, Iran, and the Pan Asian Dermatology Meeting held in Seoul, Korea. His research has been published in over 1,000 Medline-referenced articles.

            Steven R Feldman

            Why publish open access?

            • Increase the visibility and readership of your research by publishing in a fully open access journal.

            • Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).

            • Freely share your work with no restrictions or paywall.

            • Retain ownership of your research through our unrestrictive publishing agreements.

            • Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.

            Find the latest tweets from @tandfmedicine

            We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.